Patents by Inventor Di KANG
Di KANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12233062Abstract: This invention provides a compound of formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention provides a pharmaceutical composition comprising the said compound.Type: GrantFiled: February 29, 2024Date of Patent: February 25, 2025Assignee: Jacobio Pharmaceuticals Co., Ltd.Inventors: Huifeng Han, Panliang Gao, Cunbo Ma, Di Kang
-
Patent number: 12175787Abstract: This application discloses a three-dimensional human pose estimation method performed by a computer device. An initialization pose estimation result of a single video frame in a video frame sequence of n views is extracted based on a neural network model. Single-frame and single-view human pose estimation is performed on the initialization pose estimation result for each video frame, to obtain n single-view pose estimation sequences respectively corresponding to the n views. Single-frame and multi-view human pose estimation is performed according to single-view pose estimation results with the same timestamp in the n single-view pose estimation sequences, to obtain a multi-view pose estimation sequence. Multi-frame and multi-view human pose estimation is performed on a multi-view pose estimation result in the multi-view pose estimation sequence, to obtain a multi-view and multi-frame pose estimation result. Therefore, accuracy of human pose estimation is improved.Type: GrantFiled: September 1, 2022Date of Patent: December 24, 2024Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITEDInventors: Weidong Chen, Wei Zhang, Di Kang, Linchao Bao
-
Publication number: 20240336629Abstract: Provided are a compound of formula (I) that inhibit the activity of PARP7, a stereoisomer thereof, a deuterated derivative thereof, or a pharmaceutically acceptable salt thereof, an intermediate to prepare the compound, a process to prepare the compound, a composition comprising the same, and the methods of using the same.Type: ApplicationFiled: January 26, 2022Publication date: October 10, 2024Inventors: Haijun LI, Mingming CHEN, Di KANG, Qinglong LI, Lei ZHANG, Man YAN, Wei LONG, Yanping WANG, Hao ZHANG, Cunbo MA, Amin LI
-
Publication number: 20240285617Abstract: This invention provides a compound of formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention provides a pharmaceutical composition comprising the said compound.Type: ApplicationFiled: February 29, 2024Publication date: August 29, 2024Inventors: Huifeng Han, Panliang Gao, Cunbo Ma, Di Kang
-
Publication number: 20240245681Abstract: This invention provides a compound of formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention provides a pharmaceutical composition comprising the said compound.Type: ApplicationFiled: February 29, 2024Publication date: July 25, 2024Inventors: Huifeng Han, Panliang Gao, Cunbo Ma, Di Kang
-
Patent number: 11978142Abstract: A method, device, and apparatus for synthesizing a motion sequence of a virtual object and a non-transitory computer-readable storage medium are disclosed. The method can include obtaining description information of a motion sequence of a virtual object, and determining a continuous motion clip set similar to at least some motions in the motion sequence based on the description information and a continuous motion clip library constructed with video materials. The method can further include synthesizing the motion sequence of the virtual object based on the continuous motion clip set, where each continuous motion clip in the continuous motion clip library includes a unique identifier of the continuous motion clip, motion information of the continuous motion clip, and a representation vector corresponding to the each continuous motion clip.Type: GrantFiled: February 25, 2022Date of Patent: May 7, 2024Assignee: TENCENT AMERICA LLCInventors: Di Kang, Jing Li, Weidong Chen, Wei Zhang, Liang Qiao, Linchao Bao
-
Publication number: 20230097009Abstract: Disclosed is use of a compound in preventing and/or treating pathogen infection in animals. The compound is 4-(3-(((2-amino-5-(2-(1-methylpiperidin-4-yl)thiazol-5-yppyridin-3-ypoxy)methyl) phenyl)-2-methylbut-3-yn-2-ol, having a structure of formula I below. The compound can effectively treat diseases (such as feline infectious peritonitis) caused by pathogen (especially virus, such as coronavirus) infection in animals, improves the survival conditions of the animals, and has better commercial value and application prospect in the field of veterinary anti-pathogen (especially virus, such as coronavirus) therapies.Type: ApplicationFiled: June 11, 2021Publication date: March 30, 2023Inventors: Di KANG, Danni LI, Xingyu LIN, Tingting LU
-
Publication number: 20220415076Abstract: This application discloses a three-dimensional human pose estimation method performed by a computer device. An initialization pose estimation result of a single video frame in a video frame sequence of n views is extracted based on a neural network model. Single-frame and single-view human pose estimation is performed on the initialization pose estimation result for each video frame, to obtain n single-view pose estimation sequences respectively corresponding to the n views. Single-frame and multi-view human pose estimation is performed according to single-view pose estimation results with the same timestamp in the n single-view pose estimation sequences, to obtain a multi-view pose estimation sequence. Multi-frame and multi-view human pose estimation is performed on a multi-view pose estimation result in the multi-view pose estimation sequence, to obtain a multi-view and multi-frame pose estimation result. Therefore, accuracy of human pose estimation is improved.Type: ApplicationFiled: September 1, 2022Publication date: December 29, 2022Inventors: Weidong CHEN, Wei ZHANG, Di KANG, Linchao BAO
-
Publication number: 20220292752Abstract: A method, device, and apparatus for synthesizing a motion sequence of a virtual object and a non-transitory computer-readable storage medium are disclosed. The method can include obtaining description information of a motion sequence of a virtual object, and determining a continuous motion clip set similar to at least some motions in the motion sequence based on the description information and a continuous motion clip library constructed with video materials. The method can further include synthesizing the motion sequence of the virtual object based on the continuous motion clip set, where each continuous motion clip in the continuous motion clip library includes a unique identifier of the continuous motion clip, motion information of the continuous motion clip, and a representation vector corresponding to the each continuous motion clip.Type: ApplicationFiled: February 25, 2022Publication date: September 15, 2022Applicant: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITEDInventors: Di KANG, Jing LI, Weidong CHEN, Wei ZHANG, Liang QIAO, Linchao BAO
-
Publication number: 20210393623Abstract: The present invention provides a compound of formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, the present invention provides a pharmaceutical composition comprising the said compound.Type: ApplicationFiled: September 26, 2019Publication date: December 23, 2021Inventors: Huifeng Han, Panliang Gao, Cunbo Ma, Di Kang
-
Patent number: 11202587Abstract: The invention encompasses novel methods of operating electrochemical sensors such as aptamer-based sensors to analyze complex samples, such as flowing whole blood both in vitro or in vivo. In such environments, electrochemical sensors are often subject to drift, which complicates the interpretation of sensor output in terms of target concentration. The method of the invention utilizes a dual-reporter recognition element that generates a first, sensing current that is responsive to target binding and to environmental factors and a second, reference current that is only affected by environmental factors. The reference current provides information about environmentally-induced drift, which allows the drift effect to be subtracted out. By removing drift artifacts, electrochemical sensors may be deployed to analyze complex samples, such as whole blood, in vivo.Type: GrantFiled: September 25, 2017Date of Patent: December 21, 2021Assignee: The Regents of the University of CaliforniaInventors: Kevin Plaxco, Hui Li, Netzahualcoyotl Arroyo Curras, Di Kang, Francesco Ricci
-
Patent number: 10988466Abstract: This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocyclic group derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.Type: GrantFiled: March 23, 2018Date of Patent: April 27, 2021Assignee: Jacobio Pharmaceuticals Co., Ltd.Inventors: Cunbo Ma, Panliang Gao, Shaojing Hu, Zilong Xu, Huifeng Han, Xinping Wu, Di Kang
-
Publication number: 20200392128Abstract: This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocyclic group derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.Type: ApplicationFiled: March 23, 2018Publication date: December 17, 2020Inventors: Cunbo Ma, Panliang Gao, Shaojing Hu, Zilong Xu, Huifeng Han, Xinping Wu, Di Kang
-
Patent number: 10858359Abstract: Provided are certain novel pyrazine derivatives (I) as SHP2 inhibitors which is shown as formula (I), their synthesis and their use for treating a SHP2 mediated disorder. More particularly, provided are fused heterocyclic derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.Type: GrantFiled: June 7, 2017Date of Patent: December 8, 2020Assignee: JACOBIO PHARMACEUTICALS CO., LTD.Inventors: Cunbo Ma, Panliang Gao, Jie Chu, Xinping Wu, Chunwei Wen, Di Kang, Jinlong Bai, Xiaoyan Pei
-
Publication number: 20190209063Abstract: The invention encompasses novel methods of operating electrochemical sensors such as aptamer-based sensors to analyze complex samples, such as flowing whole blood both in vitro or in vivo. In such environments, electrochemical sensors are often subject to drift, which complicates the interpretation of sensor output in terms of target concentration. The method of the invention utilizes a dual-reporter recognition element that generates a first, sensing current that is responsive to target binding and to environmental factors and a second, reference current that is only affected by environmental factors. The reference current provides information about environmentally-induced drift, which allows the drift effect to be subtracted out. By removing drift artifacts, electrochemical sensors may be deployed to analyze complex samples, such as whole blood, in vivo.Type: ApplicationFiled: September 25, 2017Publication date: July 11, 2019Inventors: Kevin Plaxco, Hui Li, Netzahuslcoyotl Arroyo Curras, Di Kang, Francesco Ricci
-
Publication number: 20190127378Abstract: Provided are certain novel pyrazine derivatives (I) as SHP2 inhibitors which is shown as formula (I), their synthesis and their use for treating a SHP2 mediated disorder. More particularly, provided are fused heterocyclic derivatives useful as inhibitors of SHP2, methods for producing such compounds and methods for treating a SHP2-mediated disorder.Type: ApplicationFiled: June 7, 2017Publication date: May 2, 2019Inventors: Cunbo MA, Panliang GAO, Jie CHU, Xinping WU, Chunwei WEN, Di KANG, Jinlong BAI, Xiaoyan PEI
-
Patent number: 7223730Abstract: This invention features an antithrombosis enzyme extracted and purified from the snake venom of Southern-Anhui Agkistrodon acutus and pharmaceutical uses thereof.Type: GrantFiled: August 23, 2001Date of Patent: May 29, 2007Assignee: Hefei-Siu-Fung USTC Pharmaceutical Co., Ltd.Inventors: Chun Wang, Benjamin Xy Li, Xin Cheng, Jing Liu, Li-Wen Niu, Wan-Zhi Huang, Zhen-Yu Xu, Dan Luo, Lian-Di Kang, Jin-Guo Ding, Fang Rong, Yan Liu, Hui-Ran Chen
-
Publication number: 20060153831Abstract: This invention features an antithrombosis enzyme extracted and purified from the snake venom of Southern-Anhui Agkistrodon acutus and pharmaceutical uses thereof.Type: ApplicationFiled: October 3, 2005Publication date: July 13, 2006Inventors: Chun Wang, Benjamin Li, Xin Cheng, Jing Liu, Li-Wen Niu, Wan-Zhi Huang, Zhen-Yu Xu, Dan Luo, Lian-Di Kang, Jin-Guo Ding, Fang Rong, Yan Liu, Hui-Ran Chen
-
Publication number: 20030022350Abstract: This invention features an antithrombosis enzyme extracted and purified from the snake venom of Southern-Anhui Agkistrodon acutus and pharmaceutical uses thereof.Type: ApplicationFiled: August 23, 2001Publication date: January 30, 2003Inventors: Chun Wang, Benjamin Xy Li, Xin Cheng, Jing Liu, Li-Wen Niu, Wan-Zhi Huang, Zhen-Yu Xu, Dan Luo, Lian-Di Kang, Jin-Guo Ding, Fang Rong, Yan Liu, Hui-Ran Chen